Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01799
Species: Homo sapiens
Position : chr8:11446898-11447336
Year: 2022
Title: A risk variant for Barrett's esophagus and esophageal adenocarcinoma at chr8p23.1 affects enhancer activity and implicates multiple gene targets.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: esophageal adenocarcinoma
PMID:  35766871
MONDO: MONDO:0005028
Tissue: esophagus
Tissue Ontology ID: UBERON:0001043
Cell Source: OE19
CVCL ID: CVCL_1622
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Functional perturbation assay; Enhancer activity assay; Disease-variant functional analysis
High Throughput Method: RNA-seq, ChIP-seq; eQTL analysis; GWAS
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, RT-qPCR; Luciferase reporter assay; Allele-specific reporter assay; Reporter assay
About Target Gene
Target gene : CTSB
About TF
TF name : RUNX2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
RUNX2 AndrogenReceptor netpath 167
RUNX2 FGF signaling pathway pid 55
RUNX2 Leptin netpath 98
RUNX2 Notch-mediated HES/HEY network pid 48
RUNX2 Regulation of nuclear SMAD2/3 signaling pid 82
RUNX2 Regulation of retinoblastoma protein pid 67
RUNX2 TGF_beta_Receptor netpath 220
RUNX2 YAP1- and WWTR1 (TAZ)-stimulated gene expression reactome 29
RUNX2 Hs_MAPK_Signaling_Pathway_WP382_79951 wikipathways 58
RUNX2 Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
RUNX2 Hs_Role_of_Osx_and_miRNAs_in_tooth_development_WP3971_91525 wikipathways 9
RUNX2 Hs_Bone_Morphogenic_Protein_(BMP)_Signalling_and_Regulation_WP1425_86082 wikipathways 6
RUNX2 Hs_Focal_Adhesion-PI3K-Akt-mTOR-signaling_pathway_WP3932_91101 wikipathways 8
Enhancer Associated Network
Overlapping Enhancers (hg19) 12 found
Enhancer ID Position Tissue Cell Disease
E_01792 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01793 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01794 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01795 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01796 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01797 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01798 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01800 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01837 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01838 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01839 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
E_01840 chr8:11446898-11447336 esophagus malignant cell esophageal adenocarcinoma
Expression of Target Genes for the Enhancer